Cargando…

Efficacy of Direct-Acting Antivirals in Patients with Hepatitis C Virus/Human Immunodeficiency Virus Coinfection: A Gap between Clinical Trial and Real Practice

Detalles Bibliográficos
Autor principal: Kim, Do Young
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial Office of Gut and Liver 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6254617/
https://www.ncbi.nlm.nih.gov/pubmed/30466200
http://dx.doi.org/10.5009/gnl18418
_version_ 1783373762474803200
author Kim, Do Young
author_facet Kim, Do Young
author_sort Kim, Do Young
collection PubMed
description
format Online
Article
Text
id pubmed-6254617
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Editorial Office of Gut and Liver
record_format MEDLINE/PubMed
spelling pubmed-62546172018-11-26 Efficacy of Direct-Acting Antivirals in Patients with Hepatitis C Virus/Human Immunodeficiency Virus Coinfection: A Gap between Clinical Trial and Real Practice Kim, Do Young Gut Liver Editorial Editorial Office of Gut and Liver 2018-11 2018-11-15 /pmc/articles/PMC6254617/ /pubmed/30466200 http://dx.doi.org/10.5009/gnl18418 Text en Copyright © 2018 by The Korean Society of Gastroenterology, the Korean Society of Gastrointestinal Endoscopy, the Korean Society of Neurogastroenterology and Motility, Korean College of Helicobacter and Upper Gastrointestinal Research, Korean Association the Study of Intestinal Diseases, the Korean Association for the Study of the Liver, Korean Pancreatobiliary Association, and Korean Society of Gastrointestinal Cancer. This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Editorial
Kim, Do Young
Efficacy of Direct-Acting Antivirals in Patients with Hepatitis C Virus/Human Immunodeficiency Virus Coinfection: A Gap between Clinical Trial and Real Practice
title Efficacy of Direct-Acting Antivirals in Patients with Hepatitis C Virus/Human Immunodeficiency Virus Coinfection: A Gap between Clinical Trial and Real Practice
title_full Efficacy of Direct-Acting Antivirals in Patients with Hepatitis C Virus/Human Immunodeficiency Virus Coinfection: A Gap between Clinical Trial and Real Practice
title_fullStr Efficacy of Direct-Acting Antivirals in Patients with Hepatitis C Virus/Human Immunodeficiency Virus Coinfection: A Gap between Clinical Trial and Real Practice
title_full_unstemmed Efficacy of Direct-Acting Antivirals in Patients with Hepatitis C Virus/Human Immunodeficiency Virus Coinfection: A Gap between Clinical Trial and Real Practice
title_short Efficacy of Direct-Acting Antivirals in Patients with Hepatitis C Virus/Human Immunodeficiency Virus Coinfection: A Gap between Clinical Trial and Real Practice
title_sort efficacy of direct-acting antivirals in patients with hepatitis c virus/human immunodeficiency virus coinfection: a gap between clinical trial and real practice
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6254617/
https://www.ncbi.nlm.nih.gov/pubmed/30466200
http://dx.doi.org/10.5009/gnl18418
work_keys_str_mv AT kimdoyoung efficacyofdirectactingantiviralsinpatientswithhepatitiscvirushumanimmunodeficiencyviruscoinfectionagapbetweenclinicaltrialandrealpractice